⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23148094 | 1.00 | — | — | |
| SCHEMBL29721900 | 0.84 | — | — | |
| SCHEMBL23147880 | 0.84 | — | — | |
| SCHEMBL23148023 | 0.79 | HTR2A (0.32) | — | |
| SCHEMBL23147851 | 0.77 | — | — | |
| SCHEMBL29722077 | 0.77 | — | — | |
| SCHEMBL29721868 | 0.76 | — | — | |
| SCHEMBL23147854 | 0.76 | — | — | |
| SCHEMBL23148019 | 0.74 | — | — | |
| SCHEMBL29660486 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4034108-A1 | AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS | The Global Alliance for TB Drug Development, Inc. (US) | 2022-08-03 | — | — | EP | disclosed |
| CN-114746090-A | Azaindole carboxamide compounds for the treatment of mycobacterial infections | 结核病药物开发全球联盟公司 | 2022-07-12 | — | — | CN | disclosed |